More News – Page 67
-
NewsNovel point of attack to combat dangerous tropical diseases
Researchers have compiled a high-precision inventory of the membrane proteins of cell organelles of the African sleeping sickness pathogen, offering hope for new treatment approaches for dangerous tropical diseases.
-
NewsNew study shows obesity linked to long COVID
New research has found that people with excess weight are more likely to experience long-term neurological and mental health symptoms after COVID-19, including headache, vertigo, smell and taste disorders, sleep disturbance, and depression.
-
NewsPredictive AI model can help build vaccines for future versions of a virus
Researchers have created an AI tool called EVE-Vax that can predict and design viral proteins likely to emerge in the future. For SARS-CoV-2, panels of these “designer” proteins triggered similar immune responses as real-life viral proteins that emerged during the pandemic.
-
NewsGlobal Virus Network meeting unites Caribbean and Latin America to tackle emerging viral threats
A two-day summit focused on collaborative strategies to bolster viral surveillance, diagnostics, vaccine research, and pandemic preparedness across Latin America and the Caribbean, challenges intensified by climate change and globalization.
-
NewsResearchers find new defense against hard-to-treat plant diseases
Scientists have developed a new approach to countering citrus greening and potato zebra chip diseases. Their method uses spinach antimicrobial peptides, known as defensins, which naturally defend plants.
-
NewsDiscovery opens up for new ways to treat chlamydia
Researchers have discovered a type of molecule that can kill chlamydia bacteria but spare bacteria that are important for health.
-
NewsBacteria: Recording gene activity more efficiently
Researchers have presented a step-by-step protocol for creating single bacterial transcriptomes with MATQ-seq. The protocol also includes the experimental and computer-aided analysis of the data.
-
NewsScientists engineer antibody against flu with sticky staying power
Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature flu fighter with the broad binding capacity of a more general immune system defender. Source: NIAID Colorized transmission ...
-
NewsResearchers valuate the safety and efficacy of a smallpox vaccine for preventing mpox
Researchers explored the viability and safety of LC16m8, an attenuated vaccinia virus vaccine, to prevent monkeypox. The study evaluated the immunogenicity and safety of LC16m8 across three animal species.
-
NewsScientists win award for bringing breakthrough HIV treatment lenacapavir into play
Three people have been awarded the AAAS Mani L. Bhaumik Breakthrough of the Year Award for their work on the first HIV drug to offer long-lasting protection from infection — eliminating the need for people to take a daily pill.
-
NewsSynthetic lichen points a pathway to self-healing concrete
Addressing one of the most persistent and expensive problems in construction, scientists have taken inspiration from nature to develop a synthetic lichen system to enable concrete to self-repair.
-
NewsTransforming hospital sanitation: autonomous robots for wiping and UV-C disinfection
Scientists have developed an ’Intelligent Autonomous Wiping and UV-C Disinfection Robot’ capable of automating hospital disinfection processes. The system can perform disinfection with consistent precision, significantly reducing the risk of infection within the hospital.
-
NewsGlobal review of bird flu in cats points to risk of another pandemic
Bird flu (H5N1) is rapidly evolving into the possibility of a human pandemic, say researchers who have been documenting research on bird flu in cats and calling for urgent surveillance of cats to help avoid human-to-human transmission.
-
NewsScientists discover antibiotic resistance in newly identified bacterium
Staphylococcus borealis has been found to be resistant to several different types of antibiotics, posing a potentially significant problem for the elderly.
-
NewsFoot traffic can predict COVID-19 spread in New York City neighborhoods
A new study reveals how foot traffic data from mobile devices can enhance neighborhood-level COVID-19 forecasts in New York City, providing a novel approach to predicting the spread of the SARS-CoV-2 virus and improving targeted public health interventions.
-
NewsResearchers deploy phage enzyme to restore antibiotic effect in the event of resistance
Researchers have shown that if antibiotics are administered with an enzyme called endolysin, the combined effect protects against infection by resistant bacteria in all bodily organs – including the brain, which antibiotics alone have difficulty reaching.
-
NewsResearch collaboration takes ‘one health’ approach to study Chagas disease
Researchers have received more than $4 million from federal and non-governmental organizations to support research on Chagas disease prevalence, diagnostics and treatment to benefit both dogs and humans.
-
NewsViruses under the super microscope: How influenza viruses communicate with cells
Scientists have characterized a new model of influenza A infection: binding to MHC class II complexes as an alternative receptor and the associated dynamic reorganization of the cell surface.
-
NewsDisease experts call for reinstatement of CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC)
The Society for Healthcare Epidemiology of America has called for the reinstatement of CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC), warning that decades of progress in preventing healthcare-associated infections are under threat.
-
NewsSpiritual healing sites could be linked to antibiotic-producing microorganisms
A study by AMI member Dr Gerry Quinn highlights the potential of spiritual healing sites as fertile ground for novel antibiotics, particularly from Streptomyces bacteria, known for producing the majority of current antibiotics.